ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 61 filers reported holding ESSA PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $45 | +21.6% | 24,531 | +109.0% | 0.00% | – |
| Q2 2022 | $37 | -100.0% | 11,739 | -84.8% | 0.00% | – |
| Q1 2022 | $477,000 | -64.4% | 77,166 | -18.2% | 0.00% | – |
| Q4 2021 | $1,340,000 | +37.7% | 94,390 | -22.4% | 0.00% | – |
| Q3 2021 | $973,000 | -49.0% | 121,601 | +82.1% | 0.00% | – |
| Q2 2021 | $1,908,000 | +60.2% | 66,774 | +62.9% | 0.00% | – |
| Q1 2021 | $1,191,000 | +868.3% | 40,991 | +298.6% | 0.00% | – |
| Q4 2020 | $123,000 | – | 10,284 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 3,525,457 | $50,061,000 | 5.01% |
| MPM BioImpact LLC | 668,688 | $9,495,000 | 1.73% |
| BVF INC/IL | 2,851,461 | $40,491,000 | 1.47% |
| Altium Capital Management LP | 345,000 | $4,899,000 | 1.35% |
| Logos Global Management LP | 865,000 | $12,283,000 | 1.27% |
| Lynwood Capital Management Inc. | 57,181 | $812,000 | 0.78% |
| Avidity Partners Management LP | 2,460,000 | $34,932,000 | 0.74% |
| Bellevue Group AG | 5,034,814 | $71,495,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,461 | $5,999,000 | 0.66% |
| Omega Fund Management, LLC | 328,196 | $4,660,000 | 0.66% |